Attached files
file | filename |
---|---|
EX-4.1 - FORM OF BRIDGE NOTE - Cordex Pharma, Inc. | cdxp_ex41.htm |
EX-10.1 - EXTENSION AND BRIDGE FUNDING AGREEMENT DATED FEBRUARY , 2010 - Cordex Pharma, Inc. | cdxp_ex101.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
______________
FORM
8-K
_______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): February 17, 2010
CORDEX PHARMA, INC. | ||
(Exact name of registrant as specified in its charter) |
Nevada
|
000-33023
|
86-0982792
|
||
(State
or Other Jurisdiction of
Incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer Identification
No.)
|
7660 Fay Avenue, Suite H-373, La Jolla, CA 92037 | ||
(Address of Principal Executive Office) (Zip Code) |
(858) 551-5700 | ||
(Registrant’s telephone number, including area code) |
N/A | ||
(Former name or former address, if changed since last report) |
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM
8.01 OTHER EVENTS
On February 17, 2010, the Company entered into an agreement with its
debenture holders which, among other things, extended the maturity date of all
of its outstanding debentures until March 31, 2010. Certain debenture
holders provided funding to the Company in the aggregate amount of $50,000,
through loans to the Company, which loans are senior to all other secured loans
other than the January 2010 loans and are on a party basis with the January 2010
loans.
ITEM 9.01 FINANCIAL STATEMENTS AND
EXHIBITS.
(a) | Not applicable |
(b) | Not applicable |
(c) | Not applicable |
Exhibit
No.
|
Description
|
|
Form
of Bridge Note
|
||
Extension
and Bridge Funding Agreement dated February 17,
2010
|
1
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CORDEX
PHARMA, INC.
|
|||
Date:
February 23, 2010
|
By:
|
/s/SHEPARD GOLDBERG | |
Shepard Goldberg | |||
Chief
Executive Officer
|
|||
2